nach oben

Erschienen in:

01.03.2014 | Original Article

Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome

verfasst von: Ersin Sukru Erden, Sebahat Genc, Sedat Motor, Ihsan Ustun, Kemal Turker Ulutas, Hatice Kayim Bilgic, Suleyman Oktar, Sana Sungur, Cihangir Erem, Cumali Gokce

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnea syndrome (OSAS) is a common health problem, and associated with obesity, metabolic syndrome (MetS), and diabetes. Growing evidence shows that 25-hydroxyvitamin-D₃ (25-OH-D) insufficiency and high parathyroid hormone (PTH) levels may be correlated to glucose intolerance, MetS, obesity, and cardiovascular abnormalities similar to OSAS. Bisphenol A (BPA) is an endocrine disruptor agent which exerts a wide variety of metabolic effects. It has estrogenic activity and its exposure may contribute to weight gain, obesity, impaired glucose metabolism, and the development of diabetes, also similar to OSAS. The aim of this study is to investigate the relationships between OSAS and serum BPA, 25-OH-D, and PTH levels. This study enrolled 128 subjects, with all of the OSAS patients having been diagnosed by polysomnography. The 128 subjects were divided into three groups: a control (n = 43), a moderate OSAS (n = 23) (AHI = 15–30), and a severe OSAS groups (n = 62) (AHI > 30). The serum BPA, 25-OH-D, and PTH levels for each subject were analyzed. 25-OH-D was lower in both OSAS groups, and PTH was higher in the OSAS groups than in the control subjects. The BPA levels were higher in the severe OSAS group than the moderate OSAS and control. There was a positive correlation between the BPA and body mass index, and a negative correlation between the 25-OH-D and BPA levels in all of the individuals. OSAS is related to high BPA and PTH levels, and low vitamin D levels. There is a positive association between BPA levels and OSAS, and the severity of OSAS. These results suggest that the BPA levels may have a role in the pathogenesis of OSAS.

W.W. Flemons, J.E. Remmers, The diagnosis of sleep apnea: questionnaires and home studies. Sleep 19(10 Suppl), S243–S247 (1996)PubMed

N.M. Punjabi, The epidemiology of adult obstructive sleep apnea. Proc. Am. Thorac. Soc. 5(2), 136–143 (2008). doi:10.1513/pats.200709-155MG PubMedCentralPubMedCrossRef

Z.T. Bloomgarden, The American Diabetes Association’s 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea. Diabetes Care 34(1), e1–e6 (2011). doi:10.2337/dc11-zb01 PubMedCrossRef

L.H. Li, X.Y. Yin, C.Y. Yao, X.C. Zhu, X.H. Wu, Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese. Endocrine (2013). doi:10.1007/s12020-013-9885-2

J.A. George, S.A. Norris, H.E. van Deventer, N.J. Crowther, The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa. PLoS One 8(4), e61282 (2013). doi:10.1371/journal.pone.0061282 PubMedCentralPubMedCrossRef

T. Mete, Y. Yalcin, D. Berker, B. Ciftci, S. Guven Firat, O. Topaloglu, H. Cinar Yavuz, S. Guler, Relationship between obstructive sleep apnea syndrome and thyroid diseases. Endocrine (2013). doi:10.1007/s12020-013-9927-9

A. Barcelo, C. Esquinas, J. Pierola, M. De la Pena, M. Sanchez-de-la-Torre, J.M. Montserrat, J.M. Marin, J. Duran, M. Arque, J.M. Bauca, F. Barbe, Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea. Respiration (2012). doi:10.1159/000342748 PubMed

T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, K. Rasmussen, M. Fenger, P. Rossing, A. Linneberg, Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population. Endocrine (2013). doi:10.1007/s12020-013-9887-0

T. Skaaby, L.L. Husemoen, C. Pisinger, T. Jorgensen, B.H. Thuesen, M. Fenger, A. Linneberg, Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine 43(3), 618–625 (2013). doi:10.1007/s12020-012-9805-x PubMedCrossRef

10.

N.C. Bozkurt, E. Cakal, M. Sahin, E.C. Ozkaya, H. Firat, T. Delibasi, The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine 41(3), 518–525 (2012). doi:10.1007/s12020-012-9595-1 PubMedCrossRef

11.

L.N. Vandenberg, M.V. Maffini, C. Sonnenschein, B.S. Rubin, A.M. Soto, Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 30(1), 75–95 (2009). doi:10.1210/er.2008-0021 PubMedCrossRef

12.

A.M. Calafat, Z. Kuklenyik, J.A. Reidy, S.P. Caudill, J. Ekong, L.L. Needham, Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ. Health Perspect. 113(4), 391–395 (2005)PubMedCentralPubMedCrossRef

13.

K. Moriyama, T. Tagami, T. Akamizu, T. Usui, M. Saijo, N. Kanamoto, Y. Hataya, A. Shimatsu, H. Kuzuya, K. Nakao, Thyroid hormone action is disrupted by bisphenol A as an antagonist. J. Clin. Endocrinol. Metab. 87(11), 5185–5190 (2002)PubMedCrossRef

14.

J. Wei, Y. Lin, Y. Li, C. Ying, J. Chen, L. Song, Z. Zhou, Z. Lv, W. Xia, X. Chen, S. Xu, Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 152(8), 3049–3061 (2011). doi:10.1210/en.2011-0045 PubMedCrossRef

15.

P. Alonso-Magdalena, E. Vieira, S. Soriano, L. Menes, D. Burks, I. Quesada, A. Nadal, Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect. 118(9), 1243–1250 (2010). doi:10.1289/ehp.1001993 PubMedCentralPubMedCrossRef

16.

B.S. Rubin, A.M. Soto, Bisphenol A: perinatal exposure and body weight. Mol. Cell. Endocrinol. 304(1–2), 55–62 (2009). doi:10.1016/j.mce.2009.02.023 PubMedCentralPubMedCrossRef

17.

R.R. Newbold, E. Padilla-Banks, W.N. Jefferson, Environmental estrogens and obesity. Mol. Cell. Endocrinol. 304(1–2), 84–89 (2009). doi:10.1016/j.mce.2009.02.024 PubMedCentralPubMedCrossRef

18.

D. Melzer, N.E. Rice, C. Lewis, W.E. Henley, T.S. Galloway, Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 5(1), e8673 (2010). doi:10.1371/journal.pone.0008673 PubMedCentralPubMedCrossRef

19.

I.A. Lang, T.S. Galloway, A. Scarlett, W.E. Henley, M. Depledge, R.B. Wallace, D. Melzer, Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300(11), 1303–1310 (2008). doi:10.1001/jama.300.11.1303 PubMedCrossRef

20.

C.A. Richter, L.S. Birnbaum, F. Farabollini, R.R. Newbold, B.S. Rubin, C.E. Talsness, J.G. Vandenbergh, D.R. Walser-Kuntz, F.S. vom Saal, In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24(2), 199–224 (2007). doi:10.1016/j.reprotox.2007.06.004 PubMedCentralPubMedCrossRef

21.

M.W. Johns, A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6), 540–545 (1991)PubMed

22.

C. Iber, S. Ancoli-Israel, A. Chesson, S.F. Quan, American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. (American Academy of Sleep Medicine, Westchester, IL, 2007)

23.

L. Cobellis, N. Colacurci, E. Trabucco, C. Carpentiero, L. Grumetto, Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed. Chromatogr. 23(11), 1186–1190 (2009). doi:10.1002/bmc.1241 PubMedCrossRef

24.

M.F. Holick, Vitamin D deficiency. New Engl J Med 357(3), 266–281 (2007). doi:10.1056/NEJMra070553 PubMedCrossRef

25.

S. Reddy Vanga, M. Good, P.A. Howard, J.L. Vacek, Role of vitamin D in cardiovascular health. Am J Cardiol 106(6), 798–805 (2010). doi:10.1016/j.amjcard.2010.04.042 PubMedCrossRef

26.

S.H. Pearce, T.D. Cheetham, Diagnosis and management of vitamin D deficiency. BMJ 340, b5664 (2010). doi:10.1136/bmj.b5664 PubMedCrossRef

27.

A. Fraser, D. Williams, D.A. Lawlor, Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001–2006). PLoS One 5(11), e13882 (2010). doi:10.1371/journal.pone.0013882 PubMedCentralPubMedCrossRef

28.

G. Zhao, E.S. Ford, C. Li, Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U.S. adults without physician-diagnosed diabetes: NHANES, 2003–2006. Diabetes Care 33(2), 344–347 (2010). doi:10.2337/dc09-0924 PubMedCrossRef

29.

J.P. Reis, D. von Muhlen, E.R. Miller 3rd, Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol. 159(1), 41–48 (2008). doi:10.1530/EJE-08-0072 PubMedCrossRef

30.

M.B. Snijder, R.M. van Dam, M. Visser, D.J. Deeg, J.M. Dekker, L.M. Bouter, J.C. Seidell, P. Lips, Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J. Clin. Endocrinol. Metab. 90(7), 4119–4123 (2005). doi:10.1210/jc.2005-0216 PubMedCrossRef

31.

K.A. Young, C.D. Engelman, C.D. Langefeld, K.G. Hairston, S.M. Haffner, M. Bryer-Ash, J.M. Norris, Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J. Clin. Endocrinol. Metab. 94(9), 3306–3313 (2009). doi:10.1210/jc.2009-0079 PubMedCrossRef

32.

T. Mete, Y. Yalcin, D. Berker, B. Ciftci, S.F. Guven, O. Topaloglu, H.C. Yavuz, S. Guler, Obstructive sleep apnea syndrome and its association with vitamin D deficiency. J. Endocrinol. Invest. (2013). doi:10.3275/8923 PubMed

33.

M.F. McCarty, C.A. Thomas, PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med. Hypotheses 61(5–6), 535–542 (2003)PubMedCrossRef

34.

S. Arunabh, S. Pollack, J. Yeh, J.F. Aloia, Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 88(1), 157–161 (2003)PubMedCrossRef

35.

J. Wortsman, L.Y. Matsuoka, T.C. Chen, Z. Lu, M.F. Holick, Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 72(3), 690–693 (2000)PubMed

36.

H. Uzkeser, K. Yildirim, B. Aktan, S. Karatay, H. Kaynar, O. Araz, K. Kilic, Bone mineral density in patients with obstructive sleep apnea syndrome. Sleep Breath. 17(1), 339–342 (2013). doi:10.1007/s11325-012-0698-y PubMedCrossRef

37.

R.R. Newbold, E. Padilla-Banks, W.N. Jefferson, J.J. Heindel, Effects of endocrine disruptors on obesity. Int. J. Androl. 31(2), 201–208 (2008). doi:10.1111/j.1365-2605.2007.00858.x PubMedCrossRef

38.

B.S. Rubin, M.K. Murray, D.A. Damassa, J.C. King, A.M. Soto, Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 109(7), 675–680 (2001)PubMedCentralPubMedCrossRef

39.

J. Miyawaki, K. Sakayama, H. Kato, H. Yamamoto, H. Masuno, Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 14(5), 245–252 (2007)PubMedCrossRef

40.

B.T. Akingbemi, C.M. Sottas, A.I. Koulova, G.R. Klinefelter, M.P. Hardy, Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology 145(2), 592–603 (2004). doi:10.1210/en.2003-1174en.2003-1174 PubMedCrossRef

41.

A.L. Wozniak, N.N. Bulayeva, C.S. Watson, Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca²⁺ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ. Health Perspect. 113(4), 431–439 (2005)PubMedCentralPubMedCrossRef

42.

T.J. Key, P.N. Appleby, G.K. Reeves, A. Roddam, J.F. Dorgan, C. Longcope, F.Z. Stanczyk, H.E. Stephenson Jr, R.T. Falk, R. Miller, A. Schatzkin, D.S. Allen, I.S. Fentiman, D.Y. Wang, M. Dowsett, H.V. Thomas, S.E. Hankinson, P. Toniolo, A. Akhmedkhanov, K. Koenig, R.E. Shore, A. Zeleniuch-Jacquotte, F. Berrino, P. Muti, A. Micheli, V. Krogh, S. Sieri, V. Pala, E. Venturelli, G. Secreto, E. Barrett-Connor, G.A. Laughlin, M. Kabuto, S. Akiba, R.G. Stevens, K. Neriishi, C.E. Land, J.A. Cauley, L.H. Kuller, S.R. Cummings, K.J. Helzlsouer, A.J. Alberg, T.L. Bush, G.W. Comstock, G.B. Gordon, S.R. Miller, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst. 95(16), 1218–1226 (2003)PubMedCrossRef

43.

C. Teng, B. Goodwin, K. Shockley, M. Xia, R. Huang, J. Norris, B. Alex Merrick, A.M. Jetten, C.P. Austin, R.R. Tice, Bisphenol A affects androgen receptor function via multiple mechanisms. Chem. Biol. Interact. (2013). doi:10.1016/j.cbi.2013.03.013 PubMed

44.

H.J. Lee, S. Chattopadhyay, E.Y. Gong, R.S. Ahn, K. Lee, Antiandrogenic effects of bisphenol A and nonylphenol on the function of androgen receptor. Toxicol. Sci. 75(1), 40–46 (2003). doi:10.1093/toxsci/kfg150 PubMedCrossRef

45.

P.J. Saylor, M.R. Smith, Metabolic complications of androgen deprivation therapy for prostate cancer. J. Urol. 189(1 Suppl), S34–S42 (2013). doi:10.1016/j.juro.2012.11.017. discussion S43–42PubMedCrossRef

46.

E.A. Lucassen, K.I. Rother, G. Cizza, Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann. N. Y. Acad. Sci. 1264(1), 110–134 (2012). doi:10.1111/j.1749-6632.2012.06655.x PubMedCentralPubMedCrossRef

47.

C.J. Gu, M. Li, Q.Y. Li, N. Li, G.C. Shi, H.Y. Wan, Obstructive sleep apnea is associated with impaired glucose metabolism in Han Chinese subjects. Chin. Med. J. 126(1), 5–10 (2013)PubMed

48.

P. Alonso-Magdalena, S. Morimoto, C. Ripoll, E. Fuentes, A. Nadal, The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 114(1), 106–112 (2006)PubMedCentralPubMedCrossRef

49.

S. Jayashree, D. Indumathi, N. Akilavalli, S. Sathish, J. Selvaraj, K. Balasubramanian, Effect of bisphenol-A on insulin signal transduction and glucose oxidation in liver of adult male albino rat. Environ. Toxicol. Pharmacol. 35(2), 300–310 (2013). doi:10.1016/j.etap.2012.12.016 PubMedCrossRef

50.

R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27(12), 2813–2818 (2004)PubMedCrossRef

51.

N.G. Forouhi, J. Luan, A. Cooper, B.J. Boucher, N.J. Wareham, Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57(10), 2619–2625 (2008). doi:10.2337/db08-0593 PubMedCrossRef

52.

C. Guillet, A. Masgrau, S. Walrand, Y. Boirie, Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation. Obes. Rev. 13(Suppl 2), 51–57 (2012). doi:10.1111/j.1467-789X.2012.01037.x PubMedCrossRef

53.

D.G. Moon, D.J. Sung, Y.S. Kim, J. Cheon, J.J. Kim, Bisphenol A inhibits penile erection via alteration of histology in the rabbit. Int. J. Impot. Res. 13(5), 309–316 (2001)PubMedCrossRef

54.

J. Pant, P. Ranjan, S.B. Deshpande, Bisphenol A decreases atrial contractility involving NO-dependent G-cyclase signaling pathway. J. Appl. Toxicol. 31(7), 698–702 (2011). doi:10.1002/jat.1647 PubMedCrossRef

55.

T.W. Storer, R. Miciek, T.G. Travison, Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy. Asian J. Androl. 14(2), 204–221 (2012). doi:10.1038/aja.2011.104 PubMedCrossRef

Titel: Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome
verfasst von: Ersin Sukru Erden
Sebahat Genc
Sedat Motor
Ihsan Ustun
Kemal Turker Ulutas
Hatice Kayim Bilgic
Suleyman Oktar
Sana Sungur
Cihangir Erem
Cumali Gokce
Publikationsdatum: 01.03.2014
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-013-0022-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment

Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study

Serum levels of IgG and IgG4 in Hashimoto thyroiditis

Zinc and insulin in pancreatic beta-cells

How to decide intervention thresholds based on FRAX in central south Chinese postmenopausal women

Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin